Giuseppe Vita

14PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsAutonomic nervous systemBiologically active moleculesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 11, 2022
Role of Sport Activity on Quality of Life in Charcot-Marie-Tooth 1A Patients.

Costanza Pazzaglia, Luca Padua, Claudia Stancanelli

|Apr 30, 2021
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area.

Massimo Russo, Luca Gentile, Vincenzo Di Stefano

|Jan 20, 2021
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy.

Gian Luca Vita, Maria Sframeli, Norma Licata

|Dec 15, 2020
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects.

Massimo Russo, Luca Gentile, Antonio Toscano

|Jul 26, 2020
Which are the factors influencing NIV adaptation and tolerance in ALS patients?

Massimo Russo, Carmen Bonanno, Claudia Profazio

Pageof 3